[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 564 Agreed to Senate (ATS)]








109th CONGRESS
  2d Session
S. RES. 564

  Designating September 10 through September 16, 2006, as ``National 
Polycystic Kidney Disease Awareness Week'' and supporting the goals and 
ideals of a National Polycystic Kidney Disease Awareness Week to raise 
public awareness and understanding of polycystic kidney disease and to 
  foster understanding of the impact polycystic kidney disease has on 
           patients and future generations of their families.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                           September 8, 2006

     Mr. DeWine (for himself and Mr. Kohl) submitted the following 
             resolution; which was considered and agreed to

_______________________________________________________________________

                               RESOLUTION


 
  Designating September 10 through September 16, 2006, as ``National 
Polycystic Kidney Disease Awareness Week'' and supporting the goals and 
ideals of a National Polycystic Kidney Disease Awareness Week to raise 
public awareness and understanding of polycystic kidney disease and to 
  foster understanding of the impact polycystic kidney disease has on 
           patients and future generations of their families.

Whereas polycystic kidney disease (known as ``PKD'') is the most prevalent life-
        threatening genetic disease in the United States, is a severe, 
        dominantly inherited disease that has a devastating impact, in both 
        human and economic terms, on people of all ages, and affects equally 
        people of all races, sexes, nationalities, geographic locations, and 
        income levels;
Whereas, based on prevalence estimates by the National Institutes of Health, it 
        is estimated that about 600,000 patients in the United States have a 
        genetic inheritance from 1 or both parents called polycystic kidney 
        disease, and that countless additional friends, loved ones, spouses, and 
        caregivers must shoulder the physical, emotional, and financial burdens 
        that polycystic kidney disease causes;
Whereas polycystic kidney disease, for which there is no cure, is 1 of the 4 
        leading causes of kidney failure in the United States;
Whereas the vast majority of polycystic kidney disease patients reach kidney 
        failure at an average age of 53, causing a severe strain on dialysis and 
        kidney transplantation resources and on the delivery of health care in 
        the United States, as the largest segment of the population of the 
        United States, the ``baby boomers'', continues to age;
Whereas end stage renal disease is one of the fastest growing components of the 
        Medicare budget, and polycystic kidney disease contributes to that cost 
        by an estimated $2,000,000,000 annually for dialysis, kidney 
        transplantation, and related therapies;
Whereas polycystic kidney disease is a systemic disease that causes damage to 
        the kidney and the cardiovascular, endocrine, hepatic, and 
        gastrointestinal organ systems and instills in patients a fear of an 
        unknown future with a life-threatening genetic disease and apprehension 
        over possible genetic discrimination;
Whereas the severity of the symptoms of polycystic kidney disease and the 
        limited public awareness of the disease causes many patients to live in 
        denial and forego regular visits to their physicians or to avoid 
        following good health management which would help avoid more severe 
        complications when kidney failure occurs;
Whereas people who have chronic, life-threatening diseases like polycystic 
        kidney disease have a predisposition to depression (7 times the national 
        average) and its resultant consequences due to their anxiety over pain, 
        suffering, and premature death;
Whereas the Senate and taxpayers of the United States desire to see treatments 
        and cures for disease and would like to see results from investments in 
        research conducted by the National Institutes of Health and from such 
        initiatives as the NIH Roadmap to the Future;
Whereas polycystic kidney disease is a verifiable example of how collaboration, 
        technological innovation, scientific momentum, and public-private 
        partnerships can generate therapeutic interventions that directly 
        benefit polycystic kidney disease sufferers, save billions of Federal 
        dollars under Medicare, Medicaid, and other programs for dialysis, 
        kidney transplants, immunosuppressant drugs, and related therapies, and 
        make available several thousand openings on the kidney transplant 
        waiting list;
Whereas improvements in diagnostic technology and the expansion of scientific 
        knowledge about polycystic kidney disease have led to the discovery of 
        the 3 primary genes that cause polycystic kidney disease and the 3 
        primary protein products of the genes and to the understanding of cell 
        structures and signaling pathways that cause cyst growth that has 
        produced multiple polycystic kidney disease clinical drug trials;
Whereas there are thousands of volunteers nationwide who are dedicated to 
        expanding essential research, fostering public awareness and 
        understanding of polycystic kidney disease, educating polycystic kidney 
        disease patients and their families about the disease to improve their 
        treatment and care, providing appropriate moral support, and encouraging 
        people to become organ donors; and
Whereas these volunteers engage in an annual national awareness event held 
        during the third week of September and such a week would be an 
        appropriate time to recognize National Polycystic Kidney Disease Week: 
        Now, therefore, be it
    Resolved, That the Senate--
            (1) designates September 10 through September 16, 2006, as 
        ``National Polycystic Kidney Disease Awareness Week'';
            (2) supports the goals and ideals of a National Polycystic 
        Kidney Disease Awareness Week to raise public awareness and 
        understanding of polycystic kidney disease (known as ``PKD'');
            (3) recognizes the need for additional research into a cure 
        for polycystic kidney disease; and
            (4) encourages the people of the United States and 
        interested groups to support National Polycystic Kidney 
        Awareness Week through appropriate ceremonies and activities to 
        promote public awareness of polycystic kidney disease and to 
        foster understanding of the impact of the disease on patients 
        and their families.
                                 <all>